Complex regulation of tau phosphorylation by the endothelin system in brain microvascular endothelial cells (BMVECs): link to barrier function
Clinical Science · 06.11.2024 · 138 (21) · 1329-1341
DOI: 10.1042/cs20240616 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, online erschienen am 24.10.2024. Verfasst von Eda Karakaya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, U.S.A. Hauptthemen laut MEDLINE: tau Proteins, Endothelial Cells, Endothelin-1, Brain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: U.S. Department of Veterans Affairs (VA), NINDS NIH HHS, BLRD VA.
Abstract (Originalsprache)
Endothelin-1 (ET-1), the most potent vasoconstrictor identified to date, contributes to cerebrovascular dysfunction. ET-1 levels in postmortem brain specimens from individuals diagnosed with Alzheimer’s disease (AD) and related dementias (ADRD) were shown to be related to cerebral hypoxia and disease severity. ET-1-mediated vascular dysfunction and ensuing cognitive deficits have also been reported in experimental models of AD and ADRD. Moreover, studies also showed that ET-1 secreted from brain microvascular endothelial cells (BMVECs) can affect neurovascular unit integrity in an autocrine and paracrine manner. Vascular contributions to cognitive impairment and dementia (VCID) is a leading ADRD cause known to be free of neuronal tau pathology, a hallmark of AD. However, a recent study reported cytotoxic hyperphosphorylated tau (p-tau) accumulation, which fails to bind or stabilize microtubules in BMVECs in VCID. Thus, the study aimed to determine the impact of ET-1 on tau pathology, microtubule organization, and barrier function in BMVECs. Cells were stimulated with 1 μM ET-1 for 24 h in the presence/absence of ETA (BQ123; 20 μM) or ETB (BQ788; 20 μM) receptor antagonists. Cell lysates were assayed for an array of phosphorylation site-specific antibodies and microtubule organization/stabilization markers. ET-1 stimulation increased p-tau Thr231 but decreased p-tau Ser199, Ser262, Ser396, and Ser214 levels only in the presence of ETA or ETB antagonism. ET-1 also impaired barrier function in the presence of ETA antagonism. These novel findings suggest that (1) dysregulation of endothelial tau phosphorylation may contribute to cerebral microvascular dysfunction and (2) the ET system may be an early intervention target to prevent hyperphosphorylated tau-mediated disruption of BMVEC barrier function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, U.S.A.
- Ralph H. Johnson Veterans Affairs Health Care System, Charleston, SC, U.S.A.
- Department of Neurosciences, Medical University of South Carolina, Charleston, SC, U.S.A.
ORCID-Profile: Eda Karakaya, Adviye Ergul
Förderung
- U.S. Department of Veterans Affairs (VA)
- NINDS NIH HHS
- BLRD VA
- NCATS NIH HHS
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Karakaya, E., Abdul, Y., Edwards, J., Jamil, S., Albayram, O., & Ergul, A. (2024). Complex regulation of tau phosphorylation by the endothelin system in brain microvascular endothelial cells (BMVECs): link to barrier function. Clinical Science, 138(21), 1329-1341. https://doi.org/10.1042/cs20240616
Vancouver
Karakaya E, Abdul Y, Edwards J, Jamil S, Albayram O, Ergul A. Complex regulation of tau phosphorylation by the endothelin system in brain microvascular endothelial cells (BMVECs): link to barrier function. Clinical Science. 2024;138(21):1329-1341. doi:10.1042/cs20240616
BibTeX
@article{Karakaya2024,
author = {Karakaya, Eda and Abdul, Yasir and Edwards, Jazlyn and Jamil, Sarah and Albayram, Onder and Ergul, Adviye},
title = {Complex regulation of tau phosphorylation by the endothelin system in brain microvascular endothelial cells (BMVECs): link to barrier function},
journal = {Clinical Science},
year = {2024},
volume = {138},
number = {21},
pages = {1329--1341},
doi = {10.1042/cs20240616}
}
EUVIMED